Home | Medical-Newswire.Com:
(Medical-NewsWire.com, June 19, 2017 ) The report "Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021” report provides a detailed overview of the major drivers, restraints, challenges, opportunities and strategies impacting the coagulation analyzer market along with the estimates and forecasts of the revenue and market share analysis.
Browse 96 market data tables and 57 figures spread through 167 pages and in-depth TOC on “Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021”
Early buyers will receive 10% customization on reports.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=197226392
The coagulation analyzers market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The major factor driving the growth of this market are increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide.
The report segments this market based on product, test, technology, end-users, and regions. Among the products, the clinical laboratory analyzers are expected to account for the largest share of the market. The high growth of clinical laboratory analyzers can be attributed increasing rental agreements and increasing prevalence of blood related diseases worldwide.
On the basis of type of test, the coagulation analyzers market is segmented into nine major test segments, namely, prothrombin time testing, fibrinogen testing, ACT, aPTT, d dimer testing, platelet function test, anti-factor Xa test, heparin & protamine dose response test for ACT and other coagulation tests. The prothrombin time testing is the largest test segment of this market, owing to the increasing incidence of cardiovascular and blood related diseases.
Download Free Report Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=197226392
Based on technology, the coagulation analyzers market is segmented into mechanical, optical, electrochemical and other technologies. The optical technology segment is expected to account for the largest share of the global coagulation analyzers market in 2016. This can be attributed to better flexibility and accuracy and greater application in coagulation analysis.
Based on end-users, the coagulation analyzers market are clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Rise in healthcare spending has resulted in the increasing use of coagulation analyzers market testing products in hospitals.
Based on regions, the global coagulation analyzers market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing diseases due to urbanization in North America.
Key players in the coagulation analyzers market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
USA : 1-888-600-6441